Stopping Anti-TNF Agents in Patients with Crohn's Disease in Remission: Is It a Feasible Long-term Strategy?

被引：22
作者：
Sorrentino, Dario [1 ,2 ,3 ]
Nash, Peter [4 ]
Viladomiu, Monica [2 ]
Hontecillas, Raquel [2 ]
Bassaganya-Riera, Josep [2 ]
机构：
[1] Virginia Tech, Div Gastroenterol, IBD Ctr, Caril Sch Med, Roanoke, VA 24016 USA
[2] Virginia Tech, Nutr Immunol & Mol Med Lab, Virginia Bioinformat Inst, Blacksburg, VA USA
[3] Univ Udine, Sch Med, Dept Clin & Expt Med Sci, I-33100 Udine, Italy
[4] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia
来源：
INFLAMMATORY BOWEL DISEASES | 2014年 / 20卷 / 04期
关键词：
anti-TNF agents; Crohn's disease; long term therapy; stopping biologics; immunomodulators; INFLAMMATORY-BOWEL-DISEASE; ANTITUMOR NECROSIS FACTOR; REGULATORY T-CELLS; RHEUMATISM PROVISIONAL DEFINITION; LOW-DOSE INFLIXIMAB; FOLLOW-UP; RHEUMATOLOGY/EUROPEAN LEAGUE; POSTOPERATIVE RECURRENCE; CLINICAL REMISSION; AMERICAN-COLLEGE;
D O I：
10.1097/01.MIB.0000442680.47427.bf
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：757 / 766
页数：10
相关论文
共 69 条
[1]   Phases of disease improvement unrelated to relapses [J].
Andersen, Oluf .
NATURE REVIEWS NEUROLOGY, 2012, 8 (11) :596-598
[2]   Commentary: predicting relapse in Crohn's disease patients in remission with biologics [J].
Andrews, J. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) :497-498
[3]   Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].
Baert, F ;
Noman, M ;
Vermeire, S ;
Van Assche, G ;
D'Haens, G ;
Carbonez, A ;
Rutgeerts, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608
[4]   Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease [J].
Baert, Filip ;
Moortgat, Liesbeth ;
Van Assche, Gert ;
Caenepeel, Philip ;
Vergauwe, Philippe ;
De Vos, Martine ;
Stokkers, Pieter ;
Hommes, Daniel ;
Rutgeerts, Paul ;
Vermeire, Severine ;
D'Haens, Geert .
GASTROENTEROLOGY, 2010, 138 (02) :463-468
[5]   Regulatory T Cells Reinforce Intestinal Homeostasis [J].
Barnes, Michael J. ;
Powrie, Fiona .
IMMUNITY, 2009, 31 (03) :401-411
[6]   Diagnosis and assessment of Crohn's disease: the present and the future [J].
Benevento, Gianluca ;
Avellini, Claudio ;
Terrosu, Giovanni ;
Geraci, Marco ;
Lodolo, Ilva ;
Sorrentino, Dario .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (06) :757-766
[7]   The status of diagnostic markers for inflammatory bowel disease [J].
Beniwal P. ;
Harrell L. .
Current Gastroenterology Reports, 2010, 12 (6) :479-484
[8]   The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[9]   Incidence and Clinical Significance of Immunogenicity to Infliximab in Crohn's Disease: A Critical Systematic Review [J].
Cassinotti, Andrea ;
Travis, Simon .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (08) :1264-1275
[10]   Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission [J].
Clarke, Kofi ;
Regueiro, Miguel .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (01) :174-179
1234567